@article{9708c87a648c42babbd0b931f2b400c5,
title = "Celiac Disease",
author = "Murray, {Joseph A.} and Frey, {Mark R.} and Maria Oliva-Hemker",
note = "Funding Information: Conflicts of interest The authors disclose the following: Dr Joseph Murray has received grant support in the past from the Broad Medical Research Program at CCFA and receives current grant support from the NIH and the Oberkotter Foundation. He serves on the advisory board of Celimmune, LLC. He was a past consultant to Boehringer Ingelheim and Inova Diagnostics and is currently a consultant to BioLineRx, GlaxoSmithKline (GSK), ImunnosanT, Institute for Protein Design (PvP Biologics), Takeda Pharmaceutical Company, Ltd, Innovate Biopharmaceuticals, Inc., Intrexon, Inova Diagnostics, MediBeacon, Inc, UCB, Allakos, Inc and Rockwell Medical, Inc. He has a patent with Evelo and receives royalties from Torax. Funding Information: Dr Maria Oliva-Hemker receives current grant support from Prometheus Labs, Janssen Pharmaceuticals and Abbott Laboratories and is a consultant for Hofflman LaRoche. Funding Information: Dr Mark Frey receives current grant support from the NIH and the Crohn{\textquoteright}s and Colitis Foundation. He serves on the scientific advisory board of Avexegen Therapeutics. ",
year = "2018",
month = jun,
doi = "10.1053/j.gastro.2017.12.026",
language = "English (US)",
volume = "154",
pages = "2005--2008",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "8",
}